Vaccines, blood, antisera, toxins and cultures in   Georgia

Exports In 2022, Georgia exported $22.7M in Vaccines, blood, antisera, toxins and cultures, making it the 60th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 37th most exported product in Georgia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Georgia are: Spain ($7.91M), Uzbekistan ($5.43M), Switzerland ($2.28M), United States ($1.58M), and Lithuania ($1.27M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Georgia between 2021 and 2022 were Spain ($7.78M), Switzerland ($2.28M), and United States ($1.56M).

Imports In 2022, Georgia imported $66.4M in Vaccines, blood, antisera, toxins and cultures, becoming the 114th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 34th most imported product in Georgia. Georgia imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($34.3M), France ($6.03M), Belgium ($5.84M), India ($2.85M), and Germany ($2.26M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Georgia between 2021 and 2022 were Switzerland ($11.5M), Lithuania ($1.59M), and Ireland ($1.05M).